Graciela Espada
Overview
Explore the profile of Graciela Espada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1007
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Silva J, Ulloa-Gutierrez R, Ivankovich-Escoto G, Yamazaki-Nakashimada M, Faugier-Fuentes E, Del Aguila O, et al.
IJID Reg
. 2024 Sep;
12:100419.
PMID: 39295841
Objectives: Our aim was to describe the epidemiology and outcomes of multisystem inflammatory syndrome in children (MIS-C) in Latin America. Methods: We conducted an observational, retrospective, and prospective multicenter study...
2.
Saper V, Tian L, Verstegen R, Conrad C, Cidon M, Hopper R, et al.
J Allergy Clin Immunol Pract
. 2024 Jul;
12(11):2996-3013.e7.
PMID: 39002722
Background: After introducing IL-1/IL-6 inhibitors, some patients with Still and Still-like disease developed unusual, often fatal, pulmonary disease. This complication was associated with scoring as DReSS (drug reaction with eosinophilia...
3.
Fernandez-Sarmiento J, Acevedo L, Nino-Serna L, Boza R, Garcia-Silva J, Yock-Corrales A, et al.
J Intensive Care Med
. 2024 Feb;
39(8):785-793.
PMID: 38414438
Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 varies widely in its presentation and severity, with low mortality in high-income countries. In this study in 16 Latin...
4.
Borgia R, De Cunto C, Terreri M, Guerini L, Espada G
J Clin Rheumatol
. 2024 Jan;
PMID: 38206911
Background/purpose: Adequate transition from pediatric to adult care is associated with better adherence to treatment and better outcomes in pediatric patients with chronic diseases. There are little data on transition...
5.
Brunetto O, Cassinelli H, Espada G, Viterbo G, Meiorin S, Ahumada M, et al.
Arch Argent Pediatr
. 2023 Jun;
122(2):e202202948.
PMID: 37382585
Objective. To provide a framework for healthcare professionals managing pediatric patients who are on active glucocorticoid (GC) therapy and to develop recommendations for the prevention and treatment of GC-induced osteoporosis...
6.
Bay L, Amartino H, Antacle A, Arberas C, Berretta A, Botto H, et al.
Arch Argent Pediatr
. 2021 May;
119(3):e193-e201.
PMID: 34033424
Here we describe the current challenges of mucopolysaccharidosis type I: the need for an adequate classification, establishing its relationship to therapeutic indications; an early diagnosis, from neonatal screening, its advantages...
7.
Bay L, Amartino H, Antacle A, Arberas C, Berretta A, Botto H, et al.
Arch Argent Pediatr
. 2021 Mar;
119(2):e121-e128.
PMID: 33749201
Considering the advances made on mucopolysaccharidosis type I after the consensus study published by a group of experts in Argentina in 2008, recommendations about genetic testing, cardiological follow-up, airway care,...
8.
Ruperto N, Brunner H, Tzaribachev N, Vega-Cornejo G, Louw I, Cimaz R, et al.
J Rheumatol
. 2021 Jan;
48(7):1073-1081.
PMID: 33452173
Objective: To assess the relationship between infection risk and abatacept (ABA) exposure levels in patients with polyarticular-course juvenile idiopathic arthritis (pJIA) following treatment with subcutaneous (SC) and intravenous (IV) ABA....
9.
Rosina S, Varnier G, Pistorio A, Pilkington C, Maillard S, Civino A, et al.
J Rheumatol
. 2020 Nov;
48(6):898-906.
PMID: 33191283
Objective: To develop and test shortened versions of the Manual Muscle Test-8 (MMT-8) in juvenile dermatomyositis (JDM). Methods: Construction of reduced tools was based on a retrospective analysis of individual...
10.
Papa R, Lane T, Minden K, Touitou I, Cantarini L, Cattalini M, et al.
J Allergy Clin Immunol Pract
. 2020 Nov;
9(2):783-791.e4.
PMID: 33181346
Background: TNF receptor-associated periodic syndrome (TRAPS) is a rare autoinflammatory disease caused by dominant mutation of the TNF super family receptor 1A (TNFRSF1A) gene. Data regarding long-term treatment outcomes are...